1. Home
  2. OLMA vs SNEX Comparison

OLMA vs SNEX Comparison

Compare OLMA & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • SNEX
  • Stock Information
  • Founded
  • OLMA 2006
  • SNEX 1924
  • Country
  • OLMA United States
  • SNEX United States
  • Employees
  • OLMA N/A
  • SNEX N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • SNEX Investment Bankers/Brokers/Service
  • Sector
  • OLMA Health Care
  • SNEX Finance
  • Exchange
  • OLMA Nasdaq
  • SNEX Nasdaq
  • Market Cap
  • OLMA 299.7M
  • SNEX 4.1B
  • IPO Year
  • OLMA 2020
  • SNEX 1994
  • Fundamental
  • Price
  • OLMA $4.57
  • SNEX $93.81
  • Analyst Decision
  • OLMA Strong Buy
  • SNEX Buy
  • Analyst Count
  • OLMA 4
  • SNEX 1
  • Target Price
  • OLMA $24.50
  • SNEX N/A
  • AVG Volume (30 Days)
  • OLMA 962.9K
  • SNEX 359.7K
  • Earning Date
  • OLMA 08-05-2025
  • SNEX 08-05-2025
  • Dividend Yield
  • OLMA N/A
  • SNEX N/A
  • EPS Growth
  • OLMA N/A
  • SNEX 17.88
  • EPS
  • OLMA N/A
  • SNEX 5.90
  • Revenue
  • OLMA N/A
  • SNEX $121,723,000,000.00
  • Revenue This Year
  • OLMA N/A
  • SNEX N/A
  • Revenue Next Year
  • OLMA N/A
  • SNEX $0.21
  • P/E Ratio
  • OLMA N/A
  • SNEX $15.91
  • Revenue Growth
  • OLMA N/A
  • SNEX 68.26
  • 52 Week Low
  • OLMA $2.86
  • SNEX $47.69
  • 52 Week High
  • OLMA $16.62
  • SNEX $97.17
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 52.70
  • SNEX 70.03
  • Support Level
  • OLMA $4.12
  • SNEX $89.00
  • Resistance Level
  • OLMA $4.70
  • SNEX $92.42
  • Average True Range (ATR)
  • OLMA 0.31
  • SNEX 2.13
  • MACD
  • OLMA 0.04
  • SNEX 0.75
  • Stochastic Oscillator
  • OLMA 74.73
  • SNEX 97.76

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About SNEX StoneX Group Inc.

StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.

Share on Social Networks: